Johnson & Johnson Under Fire

In 1994, Johnson & Johnson started selling an anti-psychotic drug called Risperdal. The FDA approved it for adults with schizophrenia, but it expressly forbade Johnson & Johnson from marketing Risperdal to treat children and the elderly—there were too many dangerous side effects. Nevertheless, for more than a decade, that’s exactly what Johnson & Johnson did. And despite government sanctions for its behavior, and thousands of lawsuits, the company made billions in profits.

pp150921Johnson_Johnson_Unde-Housed.jpg
Photo by Housed

Credits

Guest:
Steven Brill - journalist and author - @StevenBrill

Host:
Madeleine Brand

Producers:
Matt Holzman, Anna Scott, Jolie Myers, Christian Bordal, Ryan Kailath